| Dr Ria Amita Lutchmeesingh, OD | |
|
Island Medical Center, Sunny Isle, Christiansted, VI 00823 | |
| (340) 773-2020 | |
| Not Available |
| Full Name | Dr Ria Amita Lutchmeesingh |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 21 Years |
| Location | Island Medical Center, Christiansted, Virgin Island |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497971550 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 38 (Virgin Island) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ophthalmology Consultants, Pc | 9739340233 | 8 |
News Archive
Medtronic, Inc. today released new data from the MVP trial that implantable defibrillator patients receiving anti-tachycardia pacing were less likely to have health care utilization after treatment as compared to those receiving shock therapy.
The State Department has released a series of fact sheets examining the U.S. government's two-year progress in Haiti. One fact sheet examines government efforts to "lessen the severity of the cholera outbreak" in Haiti.
The gene variant most strongly associated with childhood obesity and adult morbid obesity in the study is located near the PTER gene, the function of which is not known. This variant is estimated to account for up to a third of all childhood obesity, and a fifth of all cases of adult obesity.
In a letter to theFood and Drug Administration (FDA), the American Medical Association (AMA) today called for genetic testing to be conducted under the guidance of a physician, genetic counselor, or other genetics specialist. The letter was sent to the Molecular and Clinical Genetics Panel of the FDA's Medical Devices Advisory Committee regarding direct to consumer genetic tests prior to the panel's hearings on the topic, scheduled for March 8 and 9.
Patients with a certain genetic variation who received the antiplatelet drug clopidogrel had a decreased platelet response to treatment and among those who had percutaneous coronary intervention (procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries) had an increased risk of having a cardiovascular event in the following year than patients who did not have this variant, according to a study in the August 26 issue of JAMA.
› Verified 9 days ago
| Provider Name | Ophthalmology Consultants, Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1699045849 PECOS PAC ID: 9739340233 Enrollment ID: O20120410000370 |
News Archive
Medtronic, Inc. today released new data from the MVP trial that implantable defibrillator patients receiving anti-tachycardia pacing were less likely to have health care utilization after treatment as compared to those receiving shock therapy.
The State Department has released a series of fact sheets examining the U.S. government's two-year progress in Haiti. One fact sheet examines government efforts to "lessen the severity of the cholera outbreak" in Haiti.
The gene variant most strongly associated with childhood obesity and adult morbid obesity in the study is located near the PTER gene, the function of which is not known. This variant is estimated to account for up to a third of all childhood obesity, and a fifth of all cases of adult obesity.
In a letter to theFood and Drug Administration (FDA), the American Medical Association (AMA) today called for genetic testing to be conducted under the guidance of a physician, genetic counselor, or other genetics specialist. The letter was sent to the Molecular and Clinical Genetics Panel of the FDA's Medical Devices Advisory Committee regarding direct to consumer genetic tests prior to the panel's hearings on the topic, scheduled for March 8 and 9.
Patients with a certain genetic variation who received the antiplatelet drug clopidogrel had a decreased platelet response to treatment and among those who had percutaneous coronary intervention (procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries) had an increased risk of having a cardiovascular event in the following year than patients who did not have this variant, according to a study in the August 26 issue of JAMA.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ria Amita Lutchmeesingh, OD Po Box 5996, Christiansted, VI 00823-5996 Ph: (340) 773-2020 | Dr Ria Amita Lutchmeesingh, OD Island Medical Center, Sunny Isle, Christiansted, VI 00823 Ph: (340) 773-2020 |
News Archive
Medtronic, Inc. today released new data from the MVP trial that implantable defibrillator patients receiving anti-tachycardia pacing were less likely to have health care utilization after treatment as compared to those receiving shock therapy.
The State Department has released a series of fact sheets examining the U.S. government's two-year progress in Haiti. One fact sheet examines government efforts to "lessen the severity of the cholera outbreak" in Haiti.
The gene variant most strongly associated with childhood obesity and adult morbid obesity in the study is located near the PTER gene, the function of which is not known. This variant is estimated to account for up to a third of all childhood obesity, and a fifth of all cases of adult obesity.
In a letter to theFood and Drug Administration (FDA), the American Medical Association (AMA) today called for genetic testing to be conducted under the guidance of a physician, genetic counselor, or other genetics specialist. The letter was sent to the Molecular and Clinical Genetics Panel of the FDA's Medical Devices Advisory Committee regarding direct to consumer genetic tests prior to the panel's hearings on the topic, scheduled for March 8 and 9.
Patients with a certain genetic variation who received the antiplatelet drug clopidogrel had a decreased platelet response to treatment and among those who had percutaneous coronary intervention (procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries) had an increased risk of having a cardiovascular event in the following year than patients who did not have this variant, according to a study in the August 26 issue of JAMA.
› Verified 9 days ago
Dr. Jaclyn Kay Robak, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4500 Sion Farm, Unit 2, Christiansted, VI 00820 Phone: 340-773-2020 Fax: 340-778-0977 | |
Peter M Kumpitch, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: Island Medical Center Sunny Isle, 4500 Sion Ferm, Christiansted, VI 00820 Phone: 340-778-4686 Fax: 340-778-0977 | |
Vision Center Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4500 Sion Farm, Unit #2, Christiansted, VI 00820 Phone: 340-773-2020 | |
Dr. Lisa Ellen Adams, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: Sterling Optical 3000 Golden Rock Shopping Center, Suite 14, Christiansted, VI 00820 Phone: 340-773-8880 Fax: 340-773-8433 | |
Plessen Healthcare, Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5 Orange Grove, Christiansted, VI 00820 Phone: 340-715-7720 Fax: 340-713-9002 | |
Sterling Optical #680 Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3000 Golden Rock Shopping Center, Suite 14 Sterling Optical, Christiansted, VI 00820 Phone: 340-773-8880 Fax: 340-773-8433 |